Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01861457 · ClinicalTrials.gov registry record · NA
Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic
A NA study of Infectious Disease, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT01861457 is a NA study of Infectious Disease that has completed, run by Medical University of South Carolina. The registered enrollment target is 39 participants, below the 7,023-participant average among 18 other Infectious Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01861457, a NA study of Infectious Disease, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the extent to which bacterial growth in the nostrils by S. aureus, a common bacteria that is found in hospital environment, can be reduced by NOZIN® Nasal Sanitizer® antiseptic nasal swabs during the course of a typical 10-hour work period in participants known to have S. aureus in their nose passages.
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Nozin® Nasal Sanitizer®
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01861457
The ClinicalTrials.gov registry entry for NCT01861457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,023-participant average among 18 other Infectious Disease trials with a reported enrollment target (99% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01861457 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01861457 about?
NCT01861457 is a clinical study titled "Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic". The purpose of this study is to determine the extent to which bacterial growth in the nostrils by S. aureus, a common bacteria that is found in hospital environment, can be reduced by NOZIN® Nasal Sanitizer® antiseptic nasal swabs during the course of a typical 10-hour work period in participants kn...
What is the current status of trial NCT01861457?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2013-01. Estimated completion is 2013-05.
What conditions does trial NCT01861457 study?
This clinical trial studies the following conditions: Infectious Disease.
What interventions are being tested in trial NCT01861457?
The interventions under investigation include: Placebo (OTHER), Nozin® Nasal Sanitizer® (OTHER).
Who is sponsoring clinical trial NCT01861457?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01861457 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infectious Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
RECRUITING · NA
-
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
ACTIVE NOT RECRUITING · NA
-
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
ACTIVE NOT RECRUITING · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
-
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.